The relationship between microalbuminuria and the presence and extent of coronary atherosclerosis

Angiology

Volumn 61, Issue 2, 2010, Pages 184-191

  Deveci, Onur Sinan ^a   Kabakci, Giray ^a   Tulumen, Erol ^a   Okutucu, Sercan ^a   Aksoy, Hakan ^a   Kaya, Ergun Baris ^a   Canpolat, Ugur ^a   Aytemir, Kudret ^a   Tokgozoglu, Lale ^a   Oto, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Diabetes mellitus; Gensini score; Microalbuminuria

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; SCORING SYSTEM;

AGED; ALBUMINURIA; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 76649097644     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709340892     Document Type: Article

References (33)

1. Pahor M., Ela MB, Garisson RJ, Kritchevsky SB, Applegate WB Emerging noninvasive biochemical measures to predict cardiovascular risk. Arch Intern Med. 1999 ; 159 (3). 237-245.
2. Stehouwer CD, Henry RM, Dekker JM, Nijpels G., Heine RJ, Bouter LM Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction - the Hoorn Study. Kidney Int Suppl. 2004 ;(92). 42-44.
3. Quyyumi AA Prognostic value of endothelial function. Am J Cardiol. 2003 ; 91 (12A). 19-24.
4. Dinneen SF, Gerstein HC The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997 ; 157 (13). 1413-1418.
5. Jensen JS,Feldt-Rasmussen B,Strandgaard S, Schroll M., Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000 ; 35 (4). 898-903.
6. Yuyun MF, Khaw KT, Luben R., et al. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med. 2004 ; 255 (2). 247-256. (Pubitemid 38241369)
7. Mimran A., Ribstein J., Du Cailar G. Microalbuminuria in essential hypertension. Curr Opin Nephrol Hypertens. 1999 ; 8 (3). 359-363.
8. Lakka TA, Salonen R., Kaplan GA, Salonen JT Blood pressure and the progression of carotid atherosclerosis in middle-aged men. Hypertension. 1999 ; 34 (1). 51-56.
9. Schmieder RE, Schrader J., Zidek W., et al. Low-grade albuminuria and cardiovascular risk: what is the evidence ? Clin Res Cardiol. 2007 ; 96 (5). 247-257.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002 ; 39 (2 suppl 1). S1 - S266.
11. Redon J. Urinary albumin excretion: lowering the threshold of risk in hypertension. Hypertension. 2005 ; 46 (1). 19-20.
12. Zeeuw D., Parving HH, Henning RH Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006 ; 17 (8). 2100-2105. (Pubitemid 44141898)
13. Hillege HL, Janssen WM, Bak AA, et al.;. PREVEND Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001 ; 249 (6). 519-526.
14. Deckert T., Kofoed-Enevoldsen A., Norgaard K., Borch-Johnsen K., Feldt-Rasmussen B., Jensen T. Microalbuminuria: implications for micro- and macro-vascular disease. Diabetes Care. 1992 ; 15 (9). 1181-1191.
15. Rossing P. Predictors of mortality in insulin-dependent diabetes: 10-year observational follow-up study. BMJ. 1996 ; 313 (7060). 779-784.
16. Chobanian AV, Bakris GL, Black HR, et al. the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003 ; 42 (6). 1206-1252.
17. Gensini GG A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983 ; 51 (3). 606.
18. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999 ; 33 (5). 1004-1010.
19. American Diabetes Association. Clinical practice recommendations 2001. Diabetic nephropathy. Diabetes Care. 2001 ; 24 (1). 69-72.
20. Romundstad S., Holmen J., Kvenild K., Hallan H., Ellekjaer H. Microalbuminuria and all cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis. 2003 ; 42 (3). 466-473.
21. Parving H-H., Lewis JB, Ravid M., Remuzzi G., Hunsicker LG Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006 ; 69 (11). 2057-2063.
22. Sukhija S., Aronow WS, Kakar P., et al. Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol. 2006 ; 98 (3). 279-281.
23. Buggy D., Felly J., Murphy J., O'sullivan C., Walsh M. Microalbuminuria and coronary heart disease in non-diabetics. Postgrad Med J. 1993 ; 69 (815). 704-707.
24. Beatty OL, Atkinson AB, Browne J., Clarke K., Sheridan B., Bell P. Microalbuminuria does not predict cardiovascular disease in normal general practice population. Ir J Med Sci. 1993 ; 162 (4). 140-142.
25. Arnlöv J., Evans JC, Meigs JB Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005 ; 112 (7). 969-975.
26. Gerstein HC, Mann JF, Yi Q., et al. HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001 ; 286 (4). 421-426.
27. Zelmanovitz T., Gross JL, Oliveira JR, Paggi A., Tatsch M., Azevedo MJ The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care. 1997 ; 20 (4). 516-519.
28. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989 ; 32 (4). 219-226.
29. Mogensen CE Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med. 1994 ; 235 (4). 297-316.
30. Asselbergs FW, Diercks GFH, Hillege H., et al. Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND-IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004 ; 110 (18). 2809-2816.
31. Parving HH, Lehnert H., Brochner-Mortensen J., et al. Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001 ; 345 (12). 870-878. (Pubitemid 34940826)
32. Ibsen H., Olsen MH, Wachtell K., et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: a LIFE study. Hypertension. 2005 ; 45 (2). 198-202.
33. Schrader J., L1/4ders S., Kulschewski A., et al. ; the MARPLE Study Group. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective longterm study (MARPLE-Study). J Hypertens. 2006 ; 24 (3). 541-548.